New Analyses Show Novartis Entrestotm Reduced Cardiovascular Death Or Hospitalization Forheart Failure Consistently Benefitting Patients With Reduced Ejection Fractionregardless Of Prior Heart Failure Hospital Admissions Or Background Therapy Novartis